SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 📊Experiments 🤖Agents 🚦Status 📑Docs

Info

ℹVision ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

Vision Showcase Demo

Home / Wiki / Clinical_Trial: nct05980949

clinical_trial 2,096 words KG: OVERVIEW

Contents

nct05980949

Knowledge Graph

Related Analyses (12)

4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived

RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · archived Cell type vulnerability in Alzheimer's Disease (SEA-AD data)
neurodegeneration · failed Cell type vulnerability in Alzheimer's Disease (SEA-AD data
neurodegeneration · archived Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived Metabolic reprogramming in neurodegenerative disease
neurodegeneration · completed

Related Experiments (6)

Cytochrome Therapeutics
clinical · proposed · Score: 0.40 Microglial Aging and Immune Memory in Neurodegeneration — Tr
validation · proposed · Score: 0.40 Neural Stem Cell Therapy for Alzheimer's Disease
clinical · proposed · Score: 0.40 Non-Motor Symptom Progression in Parkinson's Disease — Mecha
clinical · proposed · Score: 0.40 Spinocerebellar Ataxia (SCA) Disease-Modifying Therapy Devel
validation · proposed · Score: 0.40

Sirtuin Pathway Dysfunction Validation in Parkinson's Diseas
clinical · proposed · Score: 0.40

Knowledge Graph (12 edges)

OVERVIEW biomarker_for BRAF

OVERVIEW biomarker_for ATRX

OVERVIEW activates VALOSIN

OVERVIEW therapeutic_target CXCR1

OVERVIEW regulates LETM1

OVERVIEW regulates MCU

OVERVIEW activates CHMP2B

OVERVIEW activates TARDBP

OVERVIEW activates LC3

OVERVIEW activates TBK1

SciDEX — scidex.ai — Dashboard | Atlas